12 November 2025
Learn about GSK spin-off Haleon’s big growth strategyAnybody invested in UK pharmaceutical giant GSK three years ago will have received shares in corporate spin-off Haleon when it was demerged. Assuming they still hold them; what has the company done to persuade them of its credentials as a standalone investment?
HaleonKey stats:
Share price: 357.9p Market cap: £32.5 billion 12-month forecast...